[HTML][HTML] Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5 …

C Bernard-Marty, M Mano, M Paesmans, C Accettura… - Annals of oncology, 2003 - Elsevier
Background Alkylating agents and topoisomerase-II inhibitors have been associated with
the occurrence of secondary leukemias and myelodysplastic syndromes in breast cancer …

Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5 …

C Bernard-Marty, M Mano, M Paesmans… - Annals of Oncology …, 2003 - europepmc.org
Background Alkylating agents and topoisomerase-II inhibitors have been associated with
the occurrence of secondary leukemias and myelodysplastic syndromes in breast cancer …

[HTML][HTML] Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5 …

C Bernard-Marty, M Mano, M Paesmans… - Annals of …, 2003 - annalsofoncology.org
Background Alkylating agents and topoisomerase-II inhibitors have been associated with
the occurrence of secondary leukemias and myelodysplastic syndromes in breast cancer …

[PDF][PDF] Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5 …

C Bernard-Marty, M Mano, M Paesmans, C Accettura… - Annals of …, 2003 - Citeseer
Background: Alkylating agents and topoisomerase-II inhibitors have been associated with
the occurrence of secondary leukemias and myelodysplastic syndromes in breast cancer …

Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5 …

C Bernard-Marty, M Mano… - Annals of oncology …, 2003 - pubmed.ncbi.nlm.nih.gov
Background Alkylating agents and topoisomerase-II inhibitors have been associated with
the occurrence of secondary leukemias and myelodysplastic syndromes in breast cancer …

[引用][C] Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5 …

C BERNARD-MARTY, M MANO… - Annals of …, 2003 - pascal-francis.inist.fr
Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian
randomized study comparing cyclophosphamide, methotrexate and 5-fluorouracil (CMF) …

[引用][C] Second malignancies following adjuvant chemotherapy: 6-year results from a Belgian randomized study comparing cyclophosphamide, methotrexate and 5 …

C BERNARD-MARTY, M MANO… - Annals of …, 2003 - Oxford University Press